Skip Ribbon Commands
Skip to main content

​​​​​​​​​​

​​

Primary Diagnosis

Heart Failure

Study Purpose

This study is testing the hypothesis that market-released Cardiac Resynchronization Therapy (CRT) devices containing the AdativCRT​® (aCRT) algorithm have a superior outcome compared to standard CRT devices in CRT indicated patients with normal atrio-ventricular (AV) condition and left bundle branch block (LBBB).

Principal Investigator: Hafiza Khan, MD

Trial Details

Locations: The Heart Hospital Baylor Plano

Sponsor: Medtronic

IRB Number: 014-229​

Trial Status: Enrolling

Exclusions: Adults only

​Change in Care: ​Participating in this trial will require one additional visit a year

Contact Information:

​Penni Dolton
469.814.4735
Penni.Dolton@BSWHealth.org

Full Protocol Title

AdaptResponse​

Get Detailed Information On Clinicaltrials.gov »​​

​​

​​

​​​​​​​​​​BAYLOR SCOTT & WHITE RESEARCH ​INSTITUTE​​